Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis

被引:10
作者
Van den Heede, Klaas [1 ,2 ,3 ]
Chidambaram, Swathikan [4 ,5 ]
Van Slycke, Sam [3 ,6 ,7 ]
Brusselaers, Nele [8 ,9 ]
Warfvinge, Carl Fredrik [2 ,10 ]
Ohlsson, Hakan [2 ,11 ]
Nordenstrom, Erik [1 ,2 ]
Almquist, Martin [1 ,2 ]
机构
[1] Skane Univ Hosp, Dept Surg, Lund, Sweden
[2] Lund Univ, Dept Clin Sci, Lund, Sweden
[3] OLV Clin Aalst, Dept Gen & Endocrine Surg, Aalst, Belgium
[4] Imperial Coll London, Dept Surg & Canc, London, England
[5] Hammersmith Hosp, Dept Endocrine Surg, London, England
[6] Univ Hosp Ghent, Dept Head & Skin, Ghent, Belgium
[7] AZ Damiaan, Dept Gen Surg, Oostende, Belgium
[8] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Ctr Translat Microbiome Res, Stockholm, Sweden
[9] Univ Antwerp, Global Hlth Inst, Dept Family Med & Populat Hlth, Antwerp, Belgium
[10] Lund Univ, Dept Oncol & Pathol, Lund, Sweden
[11] Ystad Hosp, Dept Surg, Ystad, Sweden
来源
BJS-BRITISH JOURNAL OF SURGERY | 2022年 / 109卷 / 02期
关键词
POPULATION-BASED ANALYSIS; SMALL-BOWEL; SURGICAL-TREATMENT; FOLLOW-UP; SURVIVAL; GUIDELINES; NEOPLASMS; DISEASE; EPIDEMIOLOGY; FIBROSIS;
D O I
10.1093/bjs/znab413
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Patients with small intestinal neuroendocrine tumours (siNETs) usually present with advanced disease. Primary tumour resection without curative intent is controversial in patients with metastatic siNETs. The aim of this meta-analysis was to investigate survival after primary tumour resection without curative intent compared with no resection in patients with metastatic siNETs. Methods A systematic literature search was performed, using MEDLINE(R) (PubMed), Embase(R), Web of Science, and the Cochrane Library up to 25 February 2021. Studies were included if survival after primary tumour resection versus no resection in patients with metastatic siNETs was reported. Results were pooled in a random-effects meta-analysis, and are reported as hazard ratios (HRs) with 95 per cent confidence intervals. Sensitivity analyses were undertaken to enable comment on the impact of important confounders. Results After screening 3659 abstracts, 16 studies, published between 1992 and 2021, met the inclusion criteria, with a total of 9428 patients. Thirteen studies reported HRs adjusted for important confounders and were included in the meta-analysis. Median overall survival was 112 (i.q.r. 82-134) months in the primary tumour resection group compared with 60 (74-88) months in the group without resection. Five-year overall survival rates were 74 (i.q.r. 67-77) and 44 (34-45) per cent respectively. Primary tumour resection was associated with improved survival compared with no resection (HR 0.55, 95 per cent c.i. 0.47 to 0.66). This effect remained in sensitivity analyses. Conclusion Primary tumour resection is associated with increased survival in patients with advanced, metastatic siNETs, even after adjusting for important confounders.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 55 条
[1]   Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study [J].
Ahmed, A. ;
Turner, G. ;
King, B. ;
Jones, L. ;
Culliford, D. ;
McCance, D. ;
Ardill, J. ;
Johnston, B. T. ;
Poston, G. ;
Rees, M. ;
Buxton-Thomas, M. ;
Caplin, M. ;
Ramage, J. K. .
ENDOCRINE-RELATED CANCER, 2009, 16 (03) :885-894
[2]   Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias [J].
Albers, Max B. ;
Almquist, Martin ;
Bergenfelz, Anders ;
Nordenstrom, Erik .
LANGENBECKS ARCHIVES OF SURGERY, 2020, 405 (02) :137-143
[3]   Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis [J].
Almond, L. M. ;
Hodson, J. ;
Ford, S. J. ;
Gourevitch, D. ;
Roberts, K. J. ;
Shah, T. ;
Isaac, J. ;
Desai, A. .
EJSO, 2017, 43 (10) :1808-1815
[4]  
Barsouk A., 2019, MED SCI, V7, P1
[5]  
Bennett S., 2020, ANN SURG
[6]   Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours [J].
Blazevic, Anela ;
Zandee, Wouter T. ;
Franssen, Gaston J. H. ;
Hofland, Johannes ;
van Velthuysen, Marie-Louise F. ;
Hofland, Leo J. ;
Feelders, Richard A. ;
de Herder, Wouter W. .
ENDOCRINE-RELATED CANCER, 2018, 25 (03) :245-254
[7]   Trends in incidence of small bowel cancer according to histology: a population-based study [J].
Bouvier, Anne-Marie ;
Robaszkiewicz, Michel ;
Jooste, Valerie ;
Cariou, Melanie ;
Drouillard, Antoine ;
Bouvier, Veronique ;
Nousbaum, Jean-Baptiste .
JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) :181-188
[8]   Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases [J].
Capurso, G. ;
Rinzivillo, M. ;
Bettini, R. ;
Boninsegna, L. ;
Delle Fave, G. ;
Falconi, M. .
BRITISH JOURNAL OF SURGERY, 2012, 99 (11) :1480-1487
[9]   Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver [J].
Citterio, D. ;
Pusceddu, S. ;
Facciorusso, A. ;
Coppa, J. ;
Milione, M. ;
Buzzoni, R. ;
Bongini, M. ;
deBraud, F. ;
Mazzaferro, V. .
EJSO, 2017, 43 (02) :380-387
[10]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342